W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

The research group led by Prof. Wang Chu from the College of Chemistry and Molecular Engineering at Peking University ...

Neurofibrillary tangles (NFTs) are neurobiological lesions that are found in brain cells of patients with Alzheimer's disease (AD). They consist of aggregates of abnormally phosphorylated tau ...

Using a novel quantitative chemoproteomic strategy, a research group led by Prof. Wang Chu from the College of Chemistry and ...

They might function as a reservoir for soluble oligomers ... amyloidogenic proteins as different as amyloid β-protein (Aβ), tau, prion protein (PrP), α-synuclein and huntingtin.

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human “mini-brains,” known as organoids. The neurotransmitter glutamate is ...

An abnormal form of the tau protein found to accumulate in the brains of Alzheimer’s disease patients ... nerve cells in the eyes of patients with Alzheimer’s disease and links this accumulation to ...